The Patent Finder

Re-Treatment for Ophthalmic Correction of Refraction

Carl Zeiss Meditec AG

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 6 of these applications claim priority to application 60/914,179, filed Apr 26, 2007. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 9,237,965Re-Treatment for Ophthalmic Correction of Refraction
In force
 · High confidence
UsedRemaining
Carl Zeiss Meditec AGIn forceHigh confidence
US 9,855,170Re-Treatment for Ophthalmic Correction of Refraction
In force
 · Medium confidence
Carl Zeiss Meditec AGIn forceMedium confidence
US 11,471,327Re-Treatment for Ophthalmic Correction of Refraction
In force
 · Medium confidence
Carl Zeiss Meditec AGIn forceMedium confidence
US 10,646,376Re-Treatment for Ophthalmic Correction of Refraction
In force
 · Medium confidence
Carl Zeiss Meditec AGIn forceMedium confidence
US 12,427,065Re-Treatment for Ophthalmic Correction of Refraction
In force
 · High confidence
Carl Zeiss Meditec AGIn forceHigh confidence
US 8,623,038Re-Treatment for Ophthalmic Correction of Refraction
In force
 · High confidence
Carl Zeiss Meditec AGIn forceHigh confidence
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited